Federal policy is reshaping American agriculture. We help clients shape what comes next.
Constitution Partners advises clients across the food and agriculture value chain on the
federal policy, regulatory oversight, and legislative developments that directly affect production,
distribution, and market access. From Farm Bill reauthorization to FDA rulemaking, we help
clients anticipate policy shifts before they become compliance obligations.
We engage with Congress, USDA, FDA, and key authorizing and appropriations committees to
position client priorities within evolving policy frameworks. Our approach integrates regulatory
insight, coalition engagement, and targeted advocacy to support compliance, mitigate risk, and
secure long-term strategic advantage
Federal scrutiny of ingredient safety is intensifying. We advise clients on<br /> FDA's GRAS framework, emerging regulatory pressure on ultra-processed foods, and legislative<br /> efforts that could redefine labeling standards, ingredient approvals, and product positioning. We<br /> help clients engage early — before the rules are written.
Domestic sourcing requirements tied to federal nutrition programs and<br /> procurement are expanding. We support compliance strategies and engage policymakers on<br /> implementation challenges, supply chain impacts, and program design.
Farm Bill reauthorization affects commodity programs, crop insurance, conservation<br /> funding, nutrition policy, and rural development. We help clients define their priorities, shape the<br /> debate, and align business objectives with federal program structures before the legislative<br /> window closes.
Federal investment in irrigation systems, watershed management, and<br /> agricultural water infrastructure is a growing appropriations and authorization priority. We help<br /> clients position projects and engage on funding decisions that affect long-term production<br /> capacity.
FSMA implementation continues to evolve across traceability,<br /> preventive controls, and produce safety. We counsel clients on FDA rulemaking, enforcement<br /> trends, and inspection protocols — helping them manage compliance risk while influencing<br /> regulatory outcomes.